Skip to main content
. 2021 Nov 4;13:191–199. doi: 10.1016/j.bioactmat.2021.10.045

Scheme 1.

Scheme 1

Scheme of mitochondrial temperature-responsive drug delivery in a DOX-resistant model of small-cell lung cancer. In contrast to nonthermoresponsive nanocarrier PAM, thermoresponsive nanocarrier PNIPAM can release DOX upon high mitochondrial temperature, which consequently damages mitochondria and reverses DOX resistance.